Related Experiment Video
Updated: Jun 20, 2026
02:35
Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues
Published on: March 22, 2024
Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.
Kyu Yeoun Won1, Hye-Rim Park, Yong-Koo Park
1Department of Pathology, College of Medicine, Kyung Hee University, Seoul, Korea.
Tumori
|August 20, 2009
Summary
High expression of Runx2 protein is linked to metastasis in osteosarcoma, a common bone cancer. This finding suggests Runx2 may serve as a valuable prognostic marker for osteosarcoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Bone Neoplasms
Background:
- Osteosarcoma is the most frequent primary bone malignancy.
- Genetic markers are being investigated for prognostic value and therapeutic targets in osteosarcoma.
- Runx2, Indian hedgehog (IHH), and Sox9 are key proteins in bone formation and cancer development.
Purpose of the Study:
- To investigate the protein expression of Runx2, IHH, and Sox9 in osteosarcoma.
- To correlate their expression with clinicopathological variables.
- To evaluate the prognostic significance of these three genes in osteosarcoma.
Main Methods:
- Utilized 48 formalin-fixed, paraffin-embedded osteosarcoma tissue microarrays.
- Performed immunohistochemical staining to evaluate Runx2, IHH, and Sox9 protein expression.
- Analyzed the relationship between gene expression and clinicopathological parameters.
Main Results:
- High Runx2 expression significantly correlated with metastasis (P = 0.015).
- High Runx2 expression showed a trend towards poorer survival rates (P = 0.056).
- No significant relationship was found between IHH or Sox9 expression and clinicopathological parameters.
Conclusions:
- Elevated Runx2 protein expression is significantly associated with tumor metastasis in osteosarcoma.
- Overexpression of Runx2 may function as a prognostic indicator in osteosarcoma.
